TXNRD1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thioredoxin reductase1(TXNRD1) acts as a key ferroptosis suppressor in CML, and its inhibition induces ferroptosis in cysteine-deplete CML cells [97].